The certification of the mass fraction of the total content and the aqua Regia extractable content of Hg in loam soil - ERM®-CC141

The certified reference material ERM-CC141 Loam Soil was released in 2010, but was not certified for the mass fraction of total Hg content and aqua regia extractable Hg content (according to ISO 11466). This report describes the additional studies performed to certify the material for Hg.JRC.D.2-Reference material

Certification of the Mass Concentrations of Calcium, Chloride, Magnesium, Ortho-Phosphate, Potassium, Sodium and of pH and Conductivity in Groundwater - Certified Reference Material ERM®-CA616

This report presents the preparation and certification of the groundwater certified reference material ERM-CA616. All the steps required for the production of this water-matrix certified reference material are described in detail, from the sampling of natural groundwater until the characterisation exercise that lead to the final assignment of the certified values, following ISO Guide 34:2009 [1] and ISO Guide 35:2006 [2]. Homogeneity and stability of the water material were investigated with dedicated studies and the certification campaign for the material characterisation was based on an inter-comparison among several experienced laboratories. IRMM organised and coordinated all the phases of this project and carried out the evaluation of data. The certified values were calculated as the unweighted mean of the laboratory means of the accepted sets of results for each parameter, see below. Uncertainties were calculated in compliance with the Guide to the Expression of Uncertainty in Measurement (GUM, ISO/IEC Guide 98-3:2008) [3]. The stated expanded uncertainties include contributions from characterisation, homogeneity and stability.JRC.DG.D.2-Reference material

Certification of the Mass Concentrations of Ammonium, Chloride, Fluoride, Magnesium, Nitrate, Ortho-Phosphate, Sulfate and of pH and Conductivity in Simulated Rainwater - Certified Reference Material ERM®-CA408

This report presents the preparation and certification of the simulated rainwater certified reference material ERM-CA408. All the steps required for the production of this water-matrix certified reference material are described in detail, from the preparation of the simulated rainwater until the characterization exercise that lead to the final assignment of the certified values, following ISO Guide 34:2009 [1] and ISO Guide 35:2006 [2]. Homogeneity and stability of the water material were investigated with dedicated studies and the certification campaign for the material characterisation was based on an inter-comparison among several experienced laboratories. IRMM organised and coordinated all the phases of this project including evaluation of data. The certified values were calculated as the unweighted mean of the laboratory means of the accepted sets of results for each parameter, see below. Uncertainties were calculated in compliance with the Guide to the Expression of Uncertainty in Measurement (GUM, ISO/IEC Guide 98-3:2008) [3]. The stated expanded uncertainties include contributions from characterisation, homogeneity and stability.JRC.DG.D.2-Reference material

Certification of the Mass Concentrations of Arsenic, Cadmium, Iron, Lead, Manganese, Mercury and Nickel in Groundwater - Certified Reference Material ERM®-CA615

This report presents the preparation and certification of groundwater reference material ERM-CA615. All steps required for the production of this water-matrix reference material are described in detail, from the sampling of natural groundwater to the characterisation exercise that lead to the final assignment of the certified values, following ISO Guide 34:2009 [1] and ISO Guide 35:2006 [2]. Homogeneity and stability of the water material were investigated with dedicated studies and the certification campaign for the material characterisation was based on an inter-comparison involving several experienced laboratories. IRMM organised and coordinated all phases of this project and carried out the evaluation of data. The certified values were calculated as the unweighted mean of the laboratory means of the accepted sets of results for each parameter, as seen below. Uncertainties were calculated in compliance with the Guide to the Expression of Uncertainty in Measurement (GUM, ISO/IEC Guide 98-3:2008) [3]. The stated expanded uncertainties include contributions from characterisation, homogeneity and long-term stability.JRC.DG.D.2-Reference material

Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up

BACKGROUND: Early results of sirolimus-eluting stent implantation showed a nearly complete abolition of neointimal hyperplasia. The question remains, however, whether the early promising results will still be evident at long-term follow-up. The objective of our study was to evaluate the efficiency of sirolimus-eluting stent implantation for up to 2 years of follow-up. METHODS AND RESULTS: Fifteen patients with de novo coronary artery disease were treated with 18-mm sirolimus-eluting Bx-Velocity stents (Cordis) loaded with 140 microg sirolimus/cm2 metal surface area in a slow release formulation. Quantitative angiography (QCA) and intravascular ultrasound (IVUS) were performed according to standard protocol. Sirolimus-eluting stent implantation was successful in all 15 patients. During the in-hospital course, 1 patient died of cerebral hemorrhage after periprocedural administration of abciximab, and 1 patient underwent repeat stenting after 2 hours because of edge dissection that led to acute occlusion. Through 6 months and up to 2 years of follow-up, no additional events occurred. QCA analysis revea

Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer:Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts

Treatment with cisplatin-containing chemotherapy regimens causes hearing loss in 40-60% of cancer patients. It has been suggested that genetic variants in the genes encoding thiopurine S-methyltransferase (TPMT) and catechol O-methyltransferase (COMT) can predict the development of cisplatin-induced ototoxicity and may explain interindividual variability in sensitivity to cisplatin-induced hearing loss. Two recently published studies however, sought to validate these findings and showed inconsistent results. The aim of this study was to evaluate the role of polymorphisms in the TPMT and COMT genes in cisplatin-induced ototoxicity. Therefore we investigated two independent cohorts of 110 Dutch and 38 Spanish patients with osteosarcoma and performed a meta-analysis including all previously published studies resulting in a total population of 664 patients with cancer. With this largest meta-analysis performed to date, we show that the influence of TPMT and COMT on the development of cisplatin-induced hearing loss may be less important than previously suggested

Accelerated menopausal changes as human disease model 'FOCUM' for the development of osteoarthritis and other degenerative disorders:protocol for a prospective cohort study

INTRODUCTION: The incidence of degenerative disorders, including osteoarthritis (OA), increases rapidly in women after menopause. However, the influence of the menopause is still insufficiently investigated due to the slowness of menopausal transition. In this study, a novel human model is used in which it is expected that menopausal-related changes will occur faster. This is the Females discontinuing Oral Contraceptives Use at Menopausal age model. The ultimate aim is to link these changes to OA and other degenerative disorders, including cardiovascular diseases, diabetes, osteoporosis and tendinopathies. METHODS AND ANALYSIS: This is a pilot observational prospective cohort study with 2 years of follow-up. Fifty women aged 50–60 who use oral contraceptive (OC) and have the intention to stop are included. Measurements are performed once before stopping OC, and four times thereafter at 6 weeks, 6 months, 1 year and 2 years. At every time point, a questionnaire is filled in and a sample of blood is drawn. At the first and final time points, a physical examination, hand radiographs and a MRI scan of one knee are performed. The primary OA outcome is progression of the MRI Osteoarthritis Knee Score. Secondary OA outcomes are the development of clinical knee and hand OA, development of knee OA according to the MRI definition, and progression of radiographic features for hand OA. Principal component analysis will be used to assess which changes occur after stopping OC. Univariate and multivariate generalised estimating equation models will be used to test for associations between these components and OA. ETHICS AND DISSEMINATION: The study has been approved by the Medical Ethics Committee of the Erasmus MC University Medical Center Rotterdam (MEC-2019-0592). All participants must give informed consent before data collection. Results will be disseminated in national and international journals. TRIAL REGISTRATION NUMBER: NL70796.078.19

TUmor-volume to breast-volume RAtio for improving COSmetic results in breast cancer patients (TURACOS); a randomized controlled trial

Background: Cosmetic result following breast conserving surgery (BCS) for cancer influences quality of life and psychosocial functioning in breast cancer patients. A preoperative prediction of expected cosmetic result following BCS is not (yet) standard clinical practice and therefore the choice for either mastectomy or BCS is still subjective. Recently, we showed that tumour volume to breast volume ratio as well as tumour location in the breast are independent predictors of superior cosmetic result following BCS. Implementation of a prediction model including both factors, has not been studied in a prospective manner. This study aims to improve cosmetic outcome by implementation of a prediction model in the treatment decision making for breast cancer patients opting for BCS. Methods/design: Multicentre, single-blinded, randomized controlled trial comparing standard preoperative work-up to a preoperative work-up with addition of the prediction model. Tumour volume to bre

Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives

Cancer genetic counselees receive individualized information regarding heightened risks and medical recommendations which is also relevant for their at-risk relatives. Unfortunately, counselees often insufficiently inform these relatives. We designed an intervention aimed at improving counselees' knowledge regarding which at-risk relatives to inform and what information to disclose, their motivation to disclose, and their self-efficacy. The intervention, offered by telephone by trained psychosocial workers, is based on the principles of Motivational Interviewing. Phase 1 of the intervention covers agenda setting, exploration, and evaluation, and phase 2 includes information provision, enhancing motivation and self-efficacy, and brainstorming for solutions to disseminate information within the family. Fidelity and acceptability of the intervention were assessed using recordings of intervention sessions and by counselee self-report. A total of 144 counselees participated. Psychosocial workers (n = 5) delivered the intervention largely as intended. Counselees highly appreciated the content of the intervention and the psychosocial workers who delivered the intervention. In the sessions, psychosocial workers provided additional and/or corrective information, and brainstorming for solutions was performed in 70 %. These results indicate that this intervention is feasible and warrants testing in clinical practice. For this, a randomized controlled trial is currently in progress to test the intervention's efficacy

Определение скорости перемещения деформаций растяжений в массиве при подземной выемке угля

Приведена швидкість переміщення деформацій в непорушеному масиві. Встановлено, що швидкість в породах середнього ступеня метаморфізму складає 15 м/добу. Середня швидкість переміщення деформацій в сланцях – 10 м/добу, в піщаниках – 15 м/добу. При повторній підробці швидкість переміщення деформацій складає 17 м/добу.Deformation’s speed travel in the virgin rock massif is given in this article. It has been determined that deformation’s speed in the rocks of medium-scale metamorphism was 15 meters over the entire circadian period. The average speed of deformation’s travel in the shale rocks is 10 meters over the entire circadian period and in the sandstone is 15 meters over the entire circadian period. During the recurring undermining the speed travel of deformations is 17 meters over the entire circadian period